Medicago Inc MDCGF

Now some talk about MDG

[fairchij]

I really have a hard time understanding the current market cap of MDG? We know this company has world leading vaccine technology and the fact that they have 3 international agreements right now and possibly 5 more would tell you that this technology is very real. What is known so far is that MDG leads all known competing technologies in all metrics...fastest to produce a vaccine, cheapest to produce a vaccine, quickest and cheapest to buildout production facilities potentially the safest and potentially the most potent. It really could be trading a whole lot higher without raising an eyebrow. As it is I guess the market is waiting for the  clinical results. If these results are as good as the animal testing this stock has got to be worth so much more than todays price. If a company captured the global flu vaccine market and the price to supply vaccines was a small fraction of all the current suppliers what would that company be worth? That is the question in my opnion. What is the risk and what is the reward.  I bought more shares today.

[Pandora]

What is likely to happen to the share price if the Phase I results come out negative? See what happened to Transition Therapeutics today. People are always nervous in waiting to see what drug results are like. One never knows what the FDA is going to come out with so naturally a little hesitation.

[Factorien]

There's no comparaison between the two companies.  One is testing phase two on ALZHEIMER decease (wich is very complicated and has no comparable) and MDG about vaccin.  We already know that the vlp thechnology works (NVAX proved it) and MDG got better results on ferret than NVAX with better imunity and better cross-protection.  Connect the dots and you'll understand MDG

[fairchij]

Just glancing at the news release I am a little suprised that TTH did not drop lower. But before I post their news it is this type comparison that makes investors guarded...MDG is not dealing with an experimental drug treatment for disease. It is dealing with a VLP. A protein shell which looks like a virus to the immune system..a decoy Nothing toxic about it? And it is this exact

[beenthere]

It's simple, really. Investors do not want to take the chance on poor results. They would rather pay a higher price for more of a sure thing. And can you blame them? So what if you pay 20% more for the stock but the risk is like down by 80%

[fairchij]

If that is the price I felt I could buy in at (under $1 post results) I would probably have one 10th of the shares I hold right now. But my thoughts are this stock will move  much higher than that if the results are in line with those from the animal testing. We know that the safety factor was good since they went through the second set of escalated injections on schedule. And the CEO

[yang68]

It's important to note that the NR from TTH was not a report of "final" results of their Phase II study. They ran into a serious problem with the ongoing trials and needed to modify the study! This type of problem needs to be revealed to the market in a timely manner. MDG has completed Phase I and all that is remaining  is to make the results known

[Probability]

  The potential off this technology is amazing and the possible applications are numerous.   Even the commitment demanded off the archaic methods of production lead to one conclusion MDG's technology is more efficient , effective and creates a much higher profit margin or savings deciding on which side off the deal you are on  ps. check out what